Canada-based Arrayus Technologies Inc. recently announced that its MRI-guided focused ultrasound system has been granted approva ...

Microbot Medical Inc. recently announced an acceleration of patient enrollment for the ACCESS-PVI human clinical trial of the Li ...

InspireMD, Inc., developer of the CGuard embolic prevention stent system for the prevention of stroke, announced that the FDA ...

IceCure Medical Ltd. announced new data from the ICE3 trial and five additional studies of the company’s ProSense cryoabla ...

InterVene, Inc., a clinical-stage medical device company that is developing interventional solutions for chronic venous ...

Medinol Ltd. announced the first-in-human (FIH) implantation of the ChampioNIR drug-eluting peripheral stent. The procedure w ...

Multidisciplinary perspectives and optimal approaches to real-world scenarios. With Carlos J. Guevara, MD, FSIR; Leigh Ann O’Banion, MD; and Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM Dr ...

Synchron recently announced positive results from the COMMAND early feasibility study, which is evaluating the safety and effica ...

Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm-diameter balloon; guidewire-free) Aortic Temporary occlusion of large blood vessels and/or ...

Cerenovus PulseRider Aneurysm Neck Bridging Device T shape, Y shape 2.7–3.5, 3.4–4.5 8.6, 10.6 ...

Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm diameter-balloon; guidewire-free) Distal Intended for temporary occlusion of large vessels ...